市場調查報告書
商品編碼
1182002
人類生殖技術全球市場規模調查和預測,按材料生殖技術(生育藥物、避孕藥)、性別和地區分析,2022-2029Global Human Reproductive Technologies Market Size study & Forecast, by Material Reproductive Technology (Infertility drugs, Contraceptive), By Gender and Regional Analysis, 2022-2029 |
人類生殖技術是幫助夫妻解決懷孕和不孕等問題的技術。
包括預後、避孕、輔助生殖技術 (ART)、同性婚姻等。受生育率下降、計劃生育推遲等因素影響,人類生殖技術市場不斷擴大。
根據國家人口統計系統,2018年美國出生人數(初步)為3,788,235人,比2017年下降2%,為32年來最低。因此,隨著出生率下降,市場預計在預測期內會增長。另一方面,市場參與者增加不孕症和增加研發活動為市場創造了有利可圖的機會。然而,有限的保險範圍阻礙了整個 2022-2029 年預測期內的市場增長。
全球人類生殖技術市場研究考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於肥胖、生活方式改變和胎齡增加導致不孕率上升,北美以最高收入佔據市場主導地位。另一方面,由於生殖技術意識的增強、西方生活方式的盛行以及醫療保健支出的增加等因素,預計亞太地區在預測期內將出現顯著增長。
本研究的目的是揭示近年來各個細分市場和國家/地區的市場規模,並預測未來幾年的市場規模。該報告旨在捕捉被調查國家工業的定性和定量方面的情況。
它還提供了有關關鍵方面的詳細信息,例如將定義市場未來增長的驅動因素和挑戰。此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Human Reproductive Technologies Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Human Reproductive Technologies assist couples having trouble with pregnancy or infertility issues etc. It includes prognostics, contraception, Assisted Reproductive Technology (ART), and same-sex procreation. The Human Reproductive Technologies market is expanding because of factors such as decreasing birth rate and delayed family planning.
According to the National Vital Statistics System, the preliminary number of births in the United States in 2018 was 3,788,235, a 2% decrease from 2017 and the lowest number of births in 32 years. Thus , with the decreasing birth rate the market is expected to grow in the forecast period Whereas, the rising infertility and growing R&D activities by market players create lucrative opportunities for the market. However, limited insurance coverage hampers the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Human Reproductive Technologies Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominates the market with highest revenue, owing to the rising infertility rates due to obesity, changing lifestyles, and rising age conceptions. Whereas, Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as growing awareness about reproductive technologies, growing adoption of western lifestyle and rising healthcare spending.
Major market players included in this report are:
CooperSurgical, Inc.
Teva Pharmaceutical Industries
AbbVie Inc.
Ferring B.V.
Merck KGaA
Genea Limited
Ivftech
Bayer AG
Recent Developments in the Market:
Global Human Reproductive Technologies Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Reproductive Technology, Gender, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Reproductive Technology:
Infertility Drugs
Contraceptive
By Gender:
Male
Female
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable